Volume : 10, Issue : 08, August – 2023
Title:
32.CERVICAL CANCER RISK CONNECTED WITH HPV INFECTION IN GYNECOLOGIC OUTDOOR PATIENTS VISITING PIMS HOSPITAL ISLAMABAD
Authors :
Dr Marina Khan, Dr Ebadullah, Dr Mian Syed Ilyas Shah, Dr Sibghat Batool, Dr. Zainab Iqbal, Dr. Tooba Baber
Abstract :
Background: Cervical cancer ranks as fourth most common cancer amongst females globally, having a projected 604,000 new cases and 342,000 demises reported annually. In Pakistan, it poses a substantial burden on women’s health, and the incidence rate is alarmingly high. Persistent HPV infection is primary reason of cervical cancer, and identifying prevalence of HPV in a specific population is crucial for targeted prevention and early detection efforts.
Aim: The key purpose of our current research is to examine the occurrence of HPV infection among gynecologic outdoor patients visiting PIMS Hospital in Islamabad, Pakistan, and assess its association with cervical cancer risk.
Methods: This study will be conducted at PIMS Hospital in Islamabad, a prominent healthcare institution serving a diverse patient population. A cross-sectional design will be employed to assess HPV prevalence among gynecologic outdoor patients. A sample of consenting patients will undergo cervical screening through Pap smears or HPV DNA testing. Demographic data, clinical histories, and lifestyle factors will be collected through structured interviews and medical records.
Results: The current research aims to give the comprehensive overview of HPV prevalence among gynecologic outdoor patients at PIMS Hospital. Statistical analyses will be performed to determine the relationship between HPV infection and cervical cancer risk. The findings will contribute to our understanding of the burden of HPV in this region and inform strategies for early detection and prevention.
Conclusion: Cervical cancer continues to be the major health challenge in Pakistan. This current research goal is to shed light on occurrence of HPV infection amongst gynecologic outdoor patients visiting PIMS Hospital in Islamabad and its association with cervical cancer risk. The results will guide healthcare policies, screening programs, and interventions to reduce occurrence and death of cervical cancer in region.
Keywords: Cervical cancer, HPV infection, gynecologic outdoor patients, PIMS Hospital, Islamabad, prevalence, risk factors, early detection, prevention.
Cite This Article:
Please cite this article in press Marina Khan et al, Cervical Cancer Risk Connected With Hpv Infection In Gynecologic Outdoor Patients Visiting Pims Hospital Islamabad, Indo Am. J. P. Sci, 2023; 10 (08).
Number of Downloads : 10
References:
1. Slama, J., Runnebaum, I. B., Scambia, G., Angeles, M. A., Bahrehmand, K., Kommoss, S., … & Cibula, D. (2023). Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study. American Journal of Obstetrics and Gynecology, 228(4), 443-e1.
2. Perkins, R. B., Wentzensen, N., Guido, R. S., & Schiffman, M. (2023). Cervical Cancer Screening: A Review. JAMA, 330(6), 547-558.
3. Montgomery, A., Durden, A., Sundararajan, S., Al-Booz, H., & Newton, C. (2023). Review of invasive cervical cancer. Obstetrics, Gynaecology & Reproductive Medicine.
4. Bizzarri, N., Pavone, M., Loverro, M., Querleu, D., Fagotti, A., & Scambia, G. (2023). Ovarian preservation in gynecologic oncology: current indications and techniques. Current Opinion in Oncology, 35(5), 401-411.
5. Qiao, H., Zhou, Q., Zhang, H., Sun, D., & Li, C. (2023). Analysis of clinical correlation between pelvic organ prolapse and HR-HPV infection. European Journal of Obstetrics & Gynecology and Reproductive Biology, 288, 170-174.
6. Cibula, D., Raspollini, M. R., Planchamp, F., Centeno, C., Chargari, C., Felix, A., … & Lindegaard, J. (2023). ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer–Update 2023. Virchows Archiv, 1-32.
7. Kusakabe, M., Taguchi, A., Sone, K., Mori, M., & Osuga, Y. (2023). Carcinogenesis and management of human papillomavirus-associated cervical cancer. International Journal of Clinical Oncology, 1-10.
8. Vadaparampil, S. T., Fuzzell, L. N., Brownstein, N. C., Fontenot, H. B., Lake, P., Michel, A., … & Perkins, R. B. (2023). A cross‐sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk‐based management consensus guidelines. Cancer.
9. Simion, L., Chitoran, E., Cirimbei, C., Stefan, D. C., Neicu, A., Tanase, B., … & Rotaru, V. (2023). A Decade of Therapeutic Challenges in Synchronous Gynecological Cancers from the Bucharest Oncological Institute. Diagnostics, 13(12), 2069.
10. Fink, G., Abdulcadir, J., & Johnson-Agbakwu, C. E. (2023). Rates of Cervical Cancer Screening and Dysplasia Among Refugees in a Health Care Safety Net System. Journal of Immigrant and Minority Health, 1-8.
11. Riano, I., Contreras-Chavez, P., Pabon, C. M., Meza, K., Kiel, L., Bejarano, S., & Florez, N. (2023). An Overview of Cervical Cancer Prevention and Control in Latin America and the Caribbean Countries. Hematology/Oncology Clinics.
12. Yao, Y., Wang, W., Liu, Y., Yong, M., Zhang, M., Yang, Y., … & Zhou, H. (2023). Efficacy and pregnancy outcomes of focused ultrasound for cervical high-grade squamous intraepithelial lesions. International Journal of Hyperthermia, 40(1), 2250936.
13. Fuzzell, L., Brownstein, N. C., Fontenot, H. B., Lake, P. W., Michel, A., Whitmer, A., … & Perkins, R. B. (2023). Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment. Elife, 12, e85682.
14. Kavira, V., Archibong, V., Ayuba, J. T., Usman, I. M., Tibaijuka, L., Owaraganise, A., & Ngonzi, J. (2023). Factors Associated with the Uptake OF Cervical Cancer Screening Among HIV-Positive Women Attending Immune Suppressed Syndrome Clinic at Mbarara Regional Referral Hospital.
15. Babakanrad, E., Mohammadian, T., Esmaeili, D., & Behzadi, P. (2023). Cervical Cancer: A Review of Epidemiology, Treatments and Anticancer Drugs. Current Cancer Therapy Reviews, 19(3), 198-212.
16. Bertolazzi, M. A., Genta, M. L. N. D., Carvalho, F., Baracat, E. C., & Carvalho, J. P. (2023). Successful Pre-Treatment Ovarian Fresh Tissue Transplantation in a Cervical Cancer Patient Undergoing Radiation Therapy: A Case Report. Cureus, 15(8).
17. Huang, S., Qi, Y., Chen, S., He, B., Chen, X., & Xu, J. (2023). Effect of heat-clearing and dampness-eliminating Chinese medicine for high-risk cervical cancer papillomavirus infection: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 10.
18. Tiiti, T. (2023). Human papillomavirus testing using self-collected cervicovaginal samples versus doctor/nurse-collected samples for cervical cancer screening in women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa (Doctoral dissertation, University of Antwerp).
19. AlShamlan, N. A., AlOmar, R. S., AlAbdulKader, A. M., AlGhamdi, F. A., Aldakheel, A. A., Al Shehri, S. A., … & Al Shammari, M. A. (2023). Beliefs and Utilization of Cervical Cancer Screening by Female Health Care Workers in Saudi Arabia Using the Health Belief Model: A Nationwide Study. International Journal of Women’s Health, 1245-1259.
20. Martinez-Gutierrez, J., Chima, S., Boyd, L., Sherwani, A., Drosdowsky, A., Karnchanachari, N., … & Emery, J. (2023). Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review. BMC cancer, 23(1), 1-28.
21. Stuebs, F. A., Beckmann, M. W., Fehm, T., Dannecker, C., Follmann, M., Langer, T., & Wesselmann, S. (2023). Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG). Journal of Cancer Research and Clinical Oncology, 1-10.
22. Degife, E. A., Oliveira, C. R., Znamierowski, E., Meyer, J. P., & Sheth, S. S. (2023). Uptake of Cervical Cancer Screening Among Female Patients Using a Mobile Medical Clinic. American Journal of Preventive Medicine.
23. Schmid, M. P., Lindegaard, J. C., Mahantshetty, U., Tanderup, K., Jürgenliemk-Schulz, I., Haie-Meder, C., … & Spampinato, S. (2023). Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image–Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study. Journal of Clinical Oncology, 41(10), 1933-1942.
24. Marchand, G., Masoud, A. T., Abdelsattar, A., King, A., Brazil, G., Ulibarri, H., … & Govindan, M. (2023). Systematic Review and Meta-analysis of Laparoscopic Radical Hysterectomy vs. Robotic Assisted Radical Hysterectomy for Early Stage Cervical Cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology.
25. Huiyun, J., Jie, D., Huan, W., Yuebo, Y., & Xiaomao, L. (2023). Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from Guangzhou, China. Journal of Infection and Public Health, 16(10), 1531-1536.